301281 Shandong Keyuan Pharmaceutical
- 40.19
- -0.90-2.19%
Shandong Keyuan Pharmaceutical News
Kangyuan Pharmaceutical (301281.SZ): Currently not involved in medical consultation business.
Gelonghui November 5th, Ke Yuan Pharmaceuticals (301281.SZ) stated on the investor interaction platform that the company is mainly engaged in the research and development, production, and sales of chemical raw materials and their formulation products, and currently does not involve medical consulting businesses.
Express News | Kexin Pharmaceutical: Fully-owned subsidiary account at banks frozen.
Keyuan Pharmaceutical: Report for the third quarter of 2024
Express News | Three consecutive boardings of Keyuan Pharmaceutical: net income in the first three quarters decreased by 40.38% year-on-year.
Express News | Kelun Pharmaceutical: The net income in the first three quarters decreased by 40.38% year-on-year.
A-share chemical pharmaceutical sector surges, Keyuan Pharmaceuticals hits the daily limit of 20%.
Glory 24th October｜Koyuan pharmaceutical rose by 20cm, Wuxi Jinghai rose by more than 10%, Chuanning Biology, hunan er-kang pharmaceutical, Shanxi Zhendong Pharmaceutical, Shandong Sito Bio-technology, Nanjing Hicin Pharmaceutical and others followed the rise.
Jinan's former richest man Gao Yuankun's capital territory is shrinking, Hongjitang listing through Keyuan Pharmaceuticals.
After resumption of trading, KeYuan Pharmaceutical has hit the limit up for two consecutive trading days.
Express News | Kangyuan Pharmaceutical: Stocks are experiencing abnormal fluctuations in trading, there are no significant undisclosed matters that should be disclosed.
Express News | More than 10 A-share listed companies disclosed the latest M&A restructuring announcements this week. China Longyuan plans to acquire the equity of 8 new energy companies owned by its controlling shareholder for 1.686 billion yuan.
Express News | Kexin Pharmaceutical: Intends to acquire 99.42% equity of Hongji Tang stocks will resume trading tomorrow.
Koyuan Pharmaceuticals (301281.SZ) is planning to acquire the controlling stake of Hongjitang and raise supporting funds. Trading will be suspended from October 8th.
GeLongHui October 8th | KeYuan Pharmaceutical (301281.SZ) announced that the company plans to purchase the controlling stake of Shandong Hongji Tang Pharmaceutical Group Co., Ltd. (referred to as "HongJiTang") through the issuance of A-share shares and other methods, and raise supporting funds. This transaction is still in the planning stage, and the company is currently in contact with the shareholders of the target company. The final transaction will be subject to the negotiations between the company and the shareholders of the target company. The main transaction parties preliminarily identified for the issuance of shares to purchase assets include Lino Investment Holdings Group Co., Ltd. (referred to as "Lino Investment"), Lino Group Co., Ltd. (referred to as "Lino".
Express News | Trading Alert: Ke Yuan Pharmaceutical intends to disclose significant matters, stocks suspended from trading.
Hoyu Pharmaceutical (301281.SZ): 6.3 million shares of restricted shares will be lifted on October 8th.
Koyuan Pharmaceutical (301281.SZ) announced on September 25th that a total of 1 shareholder applied to lift the restricted shares, with 6.3 million shares being lifted, accounting for 5.8177% of the total share capital of the company. The restriction period is 18 months from the date of the company's first public offering and listing. The unrestricted shares will start trading on October 8, 2024 (Tuesday).
Kewei Pharmaceutical (301281.SZ) 6.3 million restricted shares will be listed for trading on October 8th.
Kangyuan Pharmaceutical (301281.SZ) announced that the number of shares to be released this time before the initial public offering has been lifted...
Shandong Keyuan Pharmaceutical: Summary of Half-Year Report in 2024.
Shandong Keyuan Pharmaceutical: Half-year report for the year 2024.
Express News | By the first half of 2024, the net income of Ke Yuan Pharmaceutical Co. Ltd decreased 29.52% year-on-year to 36.19 million Yuan.
Express News | Delivery of some vitamin products from BASF has been affected by force majeure. Concept stocks have surged and over 10 listed companies have responded to their related business layout.
Kang Yuan Pharmaceuticals (301281.SZ) has partnered with Peking Nuokangda Pharmaceutical Technology Co., Ltd on the Vitamin A Palmitate Active Pharmaceutical Ingredient project.
Koyuan Pharmaceutical (301281.SZ) stated on the investor interaction platform on August 8 that the company is cooperating with Peking Nokonda Pharmaceutical Technology Co., Ltd. on the project of vitamin A palmitate active pharmaceutical ingredient, and the project is currently under development.
Express News | Keyuan Pharmaceutical: Appoints Jiang Hongsheng as the company's general manager
Analysis
Price Target
No Data
No Data